Can Frailty Guide Immunotherapy Decisions in Older Patients?



Frailty is not significantly linked to the occurrence of adverse events of grade 3 or higher but linked to higher risks for hospitalisation and mortality in older patients receiving immunotherapy.
Medscape News UK



Source link : https://www.medscape.com/viewarticle/does-frailty-affect-outcomes-older-patients-cancer-receiving-2025a1000r87?src=rss

Author :

Publish date : 2025-10-13 12:00:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version